Five new and upcoming medical devices will help your patients manage their diabetes care.
Safety and Error Prevention
Patients aged 80 years or older were more than twice as likely to visit the ED and nearly 5 times as likely to be hospitalized for insulin-related hypoglycemia than those aged 45 to 64 years.
The benefits of statin therapy no longer stand uncontested as they did early in the life cycle of the class. The pro and con camps each can point to science, but in the end it's about personalized medicine.
At-hand reminders to check blood sugar or refill a prescription may be just what the doctor needs to order.
A 34-year-old woman presents for follow-up of her type 2 diabetes mellitus and starts therapy with lisinopril. She thinks she also may be pregnant. What is the problem?
Confusion about multiple insulin products; nonadherence to the prescribed regimen; the patient’s injection technique . . . here: a look at why errors occur when insulin is prescribed—and how to prevent them.
This case focuses on duplicate therapy resulting from the use of prescription medications, which can result in serious adverse effects.
Low levels of adiponectin before pregnancy were associated with a 5-fold increased risk of gestational diabetes. This risk was 7-fold in obese or overweight women.
Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?
Incretin-based T2DM therapy is not a direct cause of pancreatitis or pancreatic cancer asserts the European Medicines Agency.